HOME >> MEDICINE >> NEWS
NHLBI awards 12 Women's Health Initiative contracts

WHAT: The Women's Health Initiative (WHI) embarks on its next phase of research with 12 new contracts awarded last week by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The studies will help explain the postmenopausal hormone therapy and other clinical trial findings and will investigate the impact of genetic and biological markers on common diseases affecting postmenopausal women. The WHI was a major 15-year research program designed to address the most frequent causes of death, disability and poor quality of life in postmenopausal women -- cardiovascular disease, cancer, and osteoporosis.

The new 2-year research projects will apply innovative technologies to study factors affecting the major diseases in postmenopausal women. Investigators will conduct their research using blood, DNA and other biological samples and clinical data from the 161, 808 postmenopausal women who participated in one or more of the three WHI clinical trials or in the observational study. The total cost of all of the awards is $18, 679, 000.

The studies, institutions, and principal investigators are (alphabetically by institution):

  • "Adipokines and Risk of Obesity-Related Diseases, Albert Einstein College of Medicine, Bronx, NY, Gloria Ho, Ph.D., M.P.H. The research team will examine the association of adipokines (physiologically active proteins from body fat cells) with cancer and stroke risk, and the role of these proteins in the association between obesity and the risk of cancer and stroke.

  • "Physical Activity, Obesity, Inflammation, and CHD in a Multi-Ethnic Cohort of Women, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, I-Min Lee, MBBS, ScD. Dr. Lee and colleagues seek to clarify the mechanisms underlying the reduced risk of CHD conferred by physical activity and lower body fat, beyond their effects on traditional risk factors. Using data from the WHI Observation
    '"/>


Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
29-Jan-2007


Page: 1 2 3 4 5

Related medicine news :

1. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
2. NHLBI and NIH statements on totally implanted permanent artificial heart
3. NHLBI offers complete guide to physical activity for a healthy heart
4. NHLBI media availability: Low-fat dietary pattern and weight change
5. NHLBI research highlights at American Heart Associations scientific sessions
6. MGH named by NHLBI as Specialized Center for Cell-Based Therapy for Heart, Lung and Blood Diseases
7. New NHLBI-sponsored study shows programs can teach children to eat healthier
8. University hospitals wins multiple national IT awards for electronic patient data bank
9. CIRM awards $3.79 million to Burnham Institute
10. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
11. Gerontological Society of America awards new Hartford Doctoral Fellowships

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NHLBI awards Women Health Initiative contracts

(Date:5/18/2013)... 18, 2013 Scott Tischler of Tischler Brothers ... These five keys to losing weight played a huge part ... of Scott Tischler, Troy was able to lose a pound ... loss program should be approached with caution and any activity ... the five keys to weight loss that Scott Tischler advocates. ...
(Date:5/18/2013)... May 18, 2013 Wine World Accessories, ... offering its customers an attractive 25% discount on Franmara ... , Customers can now purchase this electric corkscrew opener ... online transactional process. The online store ensures delivery of ... of order placement. , A spokesperson from the ...
(Date:5/18/2013)... the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), ... reaction usually to medicine (i). The first signs of ... blistering and large areas of dead skin. Some severe ... any time and seriously affect both children and adults. ... after he received kidney medicine which caused SJS (ii). ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Three new ... two health and wellness centers and one therapeutic dispensary. ... three locations, the weekend of May 25th – May ... celebrating Memorial Day. All events will take ... May 25th , Elements Therapeutic Dispensary , 10580 S. ...
(Date:5/17/2013)... 2013 Orriant is flexing its ... to businesses across the U.S. with an enhanced ... rigorous infrastructure upgrades for their telecommunications platform, which ... via voice and data. As a company ... healthcare costs and take advantage of federal ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013.  The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 ... for Science, Technology and Research (A*STAR) and Switzerland,s ... healthy volunteer has been dosed in a Phase 1 clinical ... proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first ... novel vaccine candidate and its potential to protect against H1N1 ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
Cached News: